Powerbrands drive GSK Consumer Healthcare
Premium
26 July 2019
Worldwide sales at GlaxoSmithKline's (GSK's) Consumer Healthcare business increased by 4% at constant exchange rates in the second quarter of 2019. The company said growth had been driven primarily by the performance of its powerbrands, including Sensodyne with sales growth of 7%.